KRBP
Kiromic BioPharma Inc
Employees
50
Industry
Research and Development in Biotechnology
kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times.
Loading...
Open
0.90
Mkt cap
1.4M
Volume
4.3K
High
0.90
P/E Ratio
-0.14
52-wk high
3.78
Low
0.90
Div yield
N/A
52-wk low
0.18

Portfolio Pulse from Benzinga Newsdesk
May 22, 2023 | 4:53 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.